Back to results
US 2008/0176866 A1Published application
Novel hetaryl-phenylenediamine-pyrimidines as protein kinase inhibitors
OwnerRolf Jautelat, Gerhard Siemeister +1inventors
InventorsRolf Jautelat, Gerhard Siemeister, Ulrich Luecking
Life of this patent
Estimating the term…
Abstract
The invention relates to novel hetaryl-phenylenediamine-pyrimidines and to their structurally related oxygen and sulphur analogues of the general formula I, processes for their preparation, and their use as medicaments.
Claims24
Compounds of the general formula (I) with building blocks A, B, C and D,
- in which
- R1 is halogen, —CF3, —OCF3, C1-C4-alkyl or nitro,
- R2 is a C1-C10-alkyl, C2-C10-alkenyl or C2-C10-alkynyl radical, a C3-C7-cycloalkyl or a heterocyclyl ring having 3 to 7 ring atoms, in each case optionally substituted one or more times, identically or differently, by hydroxy, —NR8R9, —NR7—C(O)—R12, —NR7—C(O)—OR12, —NR7—C(O)—NR8R9 or a monocyclic or bicyclic heteroaryl which is optionally itself substituted one or more times by hydroxy or a C1-C6-alkyl radical.
- R3 is
- (i) hydroxy, halogen, cyano, nitro, —CF3, —OCF3, —C(O)NR8R9, —C(S)NR8R9, —NR8R9, —NR7—C(O)—R2, —NR7—C(O)—OR2, —NR7—C(O)—NR8R9 or —NR7—SO2—R12 and/or
- (ii) a C1-C5-alkyl and/or C1-C5-alkoxy radical which is optionally substituted one or more times, identically or differently, by halogen, hydroxy, C1-C6-alkoxy, —CF3, —OCF3 or —NR8R9,
- m is 0-3,
- R4 and R5 are independently of one another
- (iii) hydrogen, —NHR8, —OR8, halogen, —(CO)—NR8R9 and/or
- (iv) a C1-C4-alkyl, C3-C5-alkenyl, C3-C5-alkynyl radical or a C3-C6-cycloalkyl ring, in each case optionally themselves substituted one or more times, identically or differently, by hydroxy, —NR8R9, cyano, halogen, —CF3, C1-C6-alkoxy, —OCF3 and/or C1-C6-alkyl,
- X and Y are independently of one another
- —O—, —S—, —S(O)—, —S(O)2— or —NR5—, where
- R15 is hydrogen or a C1-C6-alkyl radical, C3-C8-cycloalkyl or a heterocyclyl ring having 3 to 8 ring atoms, in each case optionally substituted one or more times, identically or differently, by hydroxy, —NR10R11, cyano, halogen, —CF3, C1-C6-alkoxy and/or —OCF3, or
- if X is —NR15—,
- —NR15— and R2 preferably alternatively together form a 3 to 6 membered ring which, in addition to the nitrogen atom, optionally comprises a further heteroatom, is optionally substituted one or more times, identically or differently, by hydroxy, C1-C6-alkyl, C1-C6-alkoxy,
- —C(O)R12, —SO2R12, halogen or the group —NR8R9, optionally comprises 1 or 2 double bonds, and/or is interrupted by a —C(O) group.
- Q is a monocyclic or bicyclic heteroaryl ring,
- R6 is
- (iii) hydrogen or
- (iv) a C1-C4-alkyl, C3-C5-alkenyl, C3-C5-alkynyl or C1-C5-alkoxy radical, a C3-C6-cycloalkyl or phenyl ring, a heterocyclyl ring having 3 to 6 ring atoms or a monocyclic heteroaryl ring, in each case optionally themselves substituted one or more times, identically or differently, by hydroxy, —NR8R9, cyano, halogen, —CF3, C1-C6-alkoxy and/or —OCF3.
- R7 is hydrogen,
- R8 and R9 are independently of one another
- hydrogen and/or a C1-C5-alkyl, C2-C5-alkenyl radical, a C3-C7-cycloalkyl and/or phenyl ring and/or a monocyclic heteroaryl ring, in each case optionally substituted one or more times, identically or differently, by hydroxy, —NR10R11, —NR7—C(O)—R12 and/or C1-C6-alkoxy, or
- R8 and R9 form together with the nitrogen atom a 5- to 7-membered ring which, in addition to the nitrogen atom, optionally comprises 1 further heteroatom and which may be substituted one or more times, identically or differently, by hydroxy, —NR10R11 and/or C1-C6-alkoxy.
- R10 and R11 are independently of one another hydrogen or a C1-C6-alkyl radical which is optionally substituted one or more times, identically or differently, by hydroxy, halogen or C1-C6-alkoxy,
- R12 is a C1-C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl radical, a C3-C7-cycloalkyl or phenyl ring, a heterocyclyl ring having 3 to 8 ring atoms or a monocyclic heteroaryl ring, in each case optionally themselves substituted one or more times, identically or differently, by hydroxy, halogen, nitro, —NR8R9, C1-C6-alkyl and/or C1-C6-alkoxy.
- R13 and R14 are independently of one another a C1-C6-alkyl, C2-C6-alkenyl and/or C2-C6-alkynyl radical, a C3-C7-cycloalkyl and/or phenyl ring, a heterocyclyl ring having 3 to 8 ring atoms and/or a monocyclic heteroaryl ring, in each case optionally themselves substituted one or more times, identically or differently, by hydroxy, —NR8R9 and/or C1-C6-alkoxy.
- R16 is a C1-C6-alkyl, C3-C6-alkenyl, C3-C6-alkynyl radical, a C3-C7-cycloalkyl or phenyl ring, a heterocyclyl ring having 3 to 8 ring atoms or a monocyclic heteroaryl ring, in each case optionally themselves substituted one or more times, identically or differently, by hydroxy, —NR8R9, cyano, halogen, —CF3, C1-C6-alkoxy and/or —OCF3,
- and the salts, diastereomers and enantiomers thereof.
26 more elements
Dependencies are inferred from the claim text.